 Alexander Horswill
Concepts (624)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Staphylococcus aureus | 102 | 2024 | 389 | 24.030 |
Why?
| | Staphylococcal Infections | 87 | 2024 | 340 | 21.610 |
Why?
| | Bacterial Proteins | 78 | 2023 | 736 | 11.580 |
Why?
| | Biofilms | 51 | 2023 | 223 | 10.220 |
Why?
| | Quorum Sensing | 34 | 2023 | 71 | 8.730 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 35 | 2023 | 191 | 7.900 |
Why?
| | Staphylococcus epidermidis | 23 | 2023 | 71 | 5.580 |
Why?
| | Gene Expression Regulation, Bacterial | 36 | 2022 | 285 | 4.780 |
Why?
| | Staphylococcus | 11 | 2022 | 69 | 3.670 |
Why?
| | Virulence Factors | 23 | 2022 | 139 | 3.570 |
Why?
| | Virulence | 27 | 2023 | 227 | 3.320 |
Why?
| | Trans-Activators | 18 | 2023 | 367 | 3.290 |
Why?
| | Peptides, Cyclic | 19 | 2019 | 253 | 3.170 |
Why?
| | Anti-Bacterial Agents | 31 | 2023 | 1481 | 2.940 |
Why?
| | Skin | 15 | 2022 | 655 | 2.680 |
Why?
| | Peptides | 16 | 2024 | 848 | 2.360 |
Why?
| | Staphylococcal Skin Infections | 8 | 2021 | 29 | 2.330 |
Why?
| | Host-Pathogen Interactions | 14 | 2024 | 295 | 1.960 |
Why?
| | Protein Kinases | 8 | 2022 | 307 | 1.790 |
Why?
| | Bacterial Adhesion | 10 | 2022 | 78 | 1.780 |
Why?
| | Neutrophils | 19 | 2023 | 1176 | 1.700 |
Why?
| | Hemolysin Proteins | 9 | 2018 | 31 | 1.600 |
Why?
| | Animals | 79 | 2023 | 31706 | 1.400 |
Why?
| | Mice | 53 | 2023 | 14869 | 1.380 |
Why?
| | Phagocytosis | 10 | 2023 | 350 | 1.310 |
Why?
| | Bacterial Toxins | 12 | 2020 | 103 | 1.300 |
Why?
| | Lipoproteins | 4 | 2024 | 159 | 1.290 |
Why?
| | Coinfection | 4 | 2023 | 120 | 1.280 |
Why?
| | Immune Evasion | 7 | 2021 | 47 | 1.210 |
Why?
| | Peptide Hydrolases | 10 | 2023 | 104 | 1.150 |
Why?
| | Fibrinogen | 6 | 2023 | 154 | 1.070 |
Why?
| | Small Molecule Libraries | 2 | 2019 | 79 | 1.060 |
Why?
| | Microbial Interactions | 2 | 2019 | 14 | 1.050 |
Why?
| | Polysaccharide-Lyases | 2 | 2016 | 11 | 1.010 |
Why?
| | Streptococcus pyogenes | 2 | 2023 | 30 | 0.990 |
Why?
| | Repressor Proteins | 4 | 2015 | 366 | 0.970 |
Why?
| | Humans | 94 | 2024 | 114689 | 0.920 |
Why?
| | Dermatitis, Atopic | 3 | 2022 | 307 | 0.910 |
Why?
| | Membrane Proteins | 7 | 2022 | 1019 | 0.900 |
Why?
| | Extracellular Space | 4 | 2014 | 116 | 0.870 |
Why?
| | Endodeoxyribonucleases | 1 | 2023 | 59 | 0.830 |
Why?
| | DNA, Bacterial | 6 | 2020 | 311 | 0.820 |
Why?
| | Bacteremia | 4 | 2020 | 160 | 0.800 |
Why?
| | Adhesins, Bacterial | 8 | 2023 | 36 | 0.800 |
Why?
| | Propionates | 7 | 2020 | 34 | 0.790 |
Why?
| | Microbial Sensitivity Tests | 13 | 2023 | 300 | 0.790 |
Why?
| | Microbiota | 6 | 2022 | 647 | 0.760 |
Why?
| | Cathepsin G | 1 | 2021 | 6 | 0.760 |
Why?
| | Metalloproteases | 2 | 2020 | 37 | 0.760 |
Why?
| | Micrococcal Nuclease | 6 | 2014 | 19 | 0.750 |
Why?
| | Agglutination Tests | 1 | 2021 | 2 | 0.740 |
Why?
| | Cell Membrane | 7 | 2021 | 680 | 0.740 |
Why?
| | Symbiosis | 2 | 2020 | 64 | 0.730 |
Why?
| | Microbial Viability | 3 | 2018 | 79 | 0.710 |
Why?
| | Chromatography, High Pressure Liquid | 5 | 2020 | 470 | 0.710 |
Why?
| | Metalloendopeptidases | 5 | 2017 | 55 | 0.710 |
Why?
| | Mutation | 25 | 2021 | 3346 | 0.710 |
Why?
| | Mass Spectrometry | 8 | 2019 | 633 | 0.680 |
Why?
| | Plant Extracts | 4 | 2020 | 154 | 0.650 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2019 | 63 | 0.650 |
Why?
| | Rabbits | 10 | 2019 | 733 | 0.650 |
Why?
| | Immunity, Innate | 8 | 2021 | 720 | 0.650 |
Why?
| | Membrane Transport Proteins | 1 | 2020 | 138 | 0.640 |
Why?
| | Mice, Inbred C57BL | 18 | 2021 | 4694 | 0.630 |
Why?
| | Dehydration | 1 | 2018 | 40 | 0.610 |
Why?
| | Yersinia pestis | 3 | 2013 | 34 | 0.600 |
Why?
| | Antibiosis | 1 | 2017 | 7 | 0.600 |
Why?
| | Disease Transmission, Infectious | 1 | 2018 | 55 | 0.590 |
Why?
| | Carrier Proteins | 4 | 2022 | 695 | 0.580 |
Why?
| | Salmonella typhimurium | 7 | 2004 | 164 | 0.570 |
Why?
| | Operating Rooms | 1 | 2018 | 86 | 0.570 |
Why?
| | Pseudomonas aeruginosa | 7 | 2023 | 298 | 0.560 |
Why?
| | Catheter-Related Infections | 8 | 2022 | 62 | 0.560 |
Why?
| | Staphylococcus lugdunensis | 1 | 2016 | 2 | 0.550 |
Why?
| | Cysteine Endopeptidases | 2 | 2013 | 60 | 0.530 |
Why?
| | Fagaceae | 1 | 2015 | 2 | 0.510 |
Why?
| | Oleanolic Acid | 1 | 2015 | 9 | 0.510 |
Why?
| | Genes, Bacterial | 8 | 2014 | 157 | 0.500 |
Why?
| | Bacteriological Techniques | 2 | 2014 | 65 | 0.500 |
Why?
| | Homoserine | 2 | 2013 | 6 | 0.500 |
Why?
| | Models, Molecular | 11 | 2021 | 1369 | 0.500 |
Why?
| | Mice, Inbred BALB C | 7 | 2022 | 1144 | 0.490 |
Why?
| | Lactones | 2 | 2013 | 54 | 0.480 |
Why?
| | Transduction, Genetic | 2 | 2014 | 113 | 0.480 |
Why?
| | Gram-Positive Bacteria | 2 | 2017 | 45 | 0.480 |
Why?
| | Extracellular Matrix | 3 | 2020 | 436 | 0.470 |
Why?
| | Hyaluronic Acid | 1 | 2016 | 190 | 0.460 |
Why?
| | Environment | 1 | 2016 | 332 | 0.460 |
Why?
| | Endonucleases | 1 | 2014 | 30 | 0.460 |
Why?
| | Disease Models, Animal | 18 | 2023 | 3535 | 0.460 |
Why?
| | Peptide Library | 6 | 2007 | 81 | 0.450 |
Why?
| | Bacteriophages | 2 | 2014 | 75 | 0.430 |
Why?
| | beta-Lactams | 2 | 2016 | 27 | 0.430 |
Why?
| | Salmonella enterica | 5 | 2003 | 49 | 0.430 |
Why?
| | Citrates | 4 | 2004 | 43 | 0.430 |
Why?
| | N-Acetylneuraminic Acid | 1 | 2013 | 8 | 0.430 |
Why?
| | Plasmids | 7 | 2013 | 343 | 0.430 |
Why?
| | DNA-Binding Proteins | 2 | 2019 | 1314 | 0.420 |
Why?
| | Endothelium, Vascular | 1 | 2019 | 847 | 0.420 |
Why?
| | Sigma Factor | 2 | 2011 | 33 | 0.420 |
Why?
| | Bone Remodeling | 1 | 2013 | 65 | 0.410 |
Why?
| | Bacillus thuringiensis | 1 | 2012 | 4 | 0.410 |
Why?
| | Hydrastis | 1 | 2012 | 3 | 0.410 |
Why?
| | Berberine | 1 | 2012 | 6 | 0.410 |
Why?
| | Mutagenesis | 2 | 2012 | 168 | 0.410 |
Why?
| | Superantigens | 4 | 2013 | 69 | 0.400 |
Why?
| | Gene Library | 2 | 2010 | 114 | 0.400 |
Why?
| | Synovial Fluid | 4 | 2022 | 56 | 0.400 |
Why?
| | Fibronectins | 3 | 2022 | 108 | 0.400 |
Why?
| | Pneumonia, Bacterial | 2 | 2023 | 106 | 0.400 |
Why?
| | Keratinocytes | 5 | 2023 | 216 | 0.390 |
Why?
| | Locomotion | 1 | 2012 | 80 | 0.390 |
Why?
| | Osteomyelitis | 1 | 2013 | 105 | 0.390 |
Why?
| | Coagulase | 3 | 2021 | 6 | 0.380 |
Why?
| | Community-Acquired Infections | 2 | 2010 | 141 | 0.380 |
Why?
| | Epithelial Cells | 3 | 2016 | 951 | 0.380 |
Why?
| | Proteins | 3 | 2006 | 908 | 0.380 |
Why?
| | Wound Infection | 2 | 2023 | 30 | 0.380 |
Why?
| | Cytotoxins | 3 | 2024 | 17 | 0.370 |
Why?
| | Genes, Reporter | 3 | 2019 | 257 | 0.370 |
Why?
| | Extracellular Traps | 2 | 2021 | 40 | 0.370 |
Why?
| | Serine Endopeptidases | 3 | 2011 | 102 | 0.370 |
Why?
| | Coenzyme A Ligases | 3 | 2003 | 11 | 0.370 |
Why?
| | Hydrogen-Ion Concentration | 4 | 2022 | 511 | 0.350 |
Why?
| | Plasma | 1 | 2012 | 211 | 0.350 |
Why?
| | Luminescent Proteins | 3 | 2011 | 166 | 0.330 |
Why?
| | Internal Fixators | 1 | 2010 | 36 | 0.330 |
Why?
| | Models, Biological | 8 | 2021 | 1621 | 0.330 |
Why?
| | Peptide Biosynthesis | 1 | 2009 | 13 | 0.330 |
Why?
| | Amino Acid Sequence | 11 | 2016 | 1982 | 0.330 |
Why?
| | Anacardiaceae | 2 | 2020 | 4 | 0.320 |
Why?
| | Molecular Sequence Data | 12 | 2014 | 2785 | 0.320 |
Why?
| | Anti-Infective Agents | 4 | 2023 | 225 | 0.310 |
Why?
| | Operon | 6 | 2018 | 59 | 0.310 |
Why?
| | Polysaccharides | 3 | 2021 | 78 | 0.310 |
Why?
| | Drug Discovery | 3 | 2019 | 123 | 0.310 |
Why?
| | Cells, Cultured | 9 | 2021 | 3886 | 0.300 |
Why?
| | Recombinant Proteins | 7 | 2015 | 1230 | 0.300 |
Why?
| | Sepsis | 3 | 2023 | 509 | 0.300 |
Why?
| | Signal Transduction | 9 | 2021 | 4513 | 0.300 |
Why?
| | DnaB Helicases | 1 | 2007 | 3 | 0.290 |
Why?
| | Inteins | 1 | 2007 | 3 | 0.290 |
Why?
| | Synechocystis | 1 | 2007 | 4 | 0.290 |
Why?
| | Protein Binding | 8 | 2017 | 1890 | 0.290 |
Why?
| | Cysteine Proteases | 2 | 2020 | 3 | 0.290 |
Why?
| | Promoter Regions, Genetic | 8 | 2018 | 1131 | 0.280 |
Why?
| | Cyclohexanones | 2 | 2017 | 8 | 0.280 |
Why?
| | Biological Assay | 3 | 2015 | 112 | 0.270 |
Why?
| | Protein Engineering | 2 | 2004 | 98 | 0.260 |
Why?
| | Base Sequence | 4 | 2023 | 2114 | 0.250 |
Why?
| | Sequence Homology, Amino Acid | 5 | 2014 | 353 | 0.250 |
Why?
| | Inflammation | 8 | 2023 | 2480 | 0.250 |
Why?
| | Escherichia coli | 3 | 2009 | 720 | 0.250 |
Why?
| | Female | 24 | 2022 | 59511 | 0.240 |
Why?
| | Antimicrobial Cationic Peptides | 4 | 2023 | 75 | 0.240 |
Why?
| | Antibodies, Monoclonal | 2 | 2022 | 1262 | 0.240 |
Why?
| | Molecular Biology | 1 | 2005 | 56 | 0.240 |
Why?
| | Aconitate Hydratase | 2 | 2002 | 16 | 0.240 |
Why?
| | Coculture Techniques | 2 | 2016 | 201 | 0.240 |
Why?
| | In Vitro Techniques | 3 | 2021 | 1016 | 0.240 |
Why?
| | Vagina | 2 | 2019 | 146 | 0.230 |
Why?
| | Structure-Activity Relationship | 3 | 2023 | 502 | 0.230 |
Why?
| | Endocarditis | 2 | 2016 | 32 | 0.230 |
Why?
| | Isocitrates | 2 | 2001 | 2 | 0.230 |
Why?
| | Oxo-Acid-Lyases | 2 | 2001 | 3 | 0.230 |
Why?
| | Biology | 1 | 2005 | 79 | 0.230 |
Why?
| | Drug Resistance, Bacterial | 2 | 2015 | 155 | 0.230 |
Why?
| | Succinates | 1 | 2023 | 18 | 0.220 |
Why?
| | Receptor, PAR-1 | 1 | 2023 | 21 | 0.220 |
Why?
| | Dermatitis | 1 | 2023 | 17 | 0.220 |
Why?
| | Swine | 4 | 2017 | 700 | 0.220 |
Why?
| | Pruritus | 1 | 2023 | 59 | 0.220 |
Why?
| | alpha-Defensins | 2 | 2021 | 11 | 0.220 |
Why?
| | Microscopy, Confocal | 3 | 2014 | 304 | 0.220 |
Why?
| | Enzymes | 1 | 2004 | 62 | 0.220 |
Why?
| | Streptococcal Infections | 2 | 2023 | 131 | 0.210 |
Why?
| | RNA, Bacterial | 4 | 2013 | 174 | 0.210 |
Why?
| | Respiratory System | 2 | 2016 | 137 | 0.210 |
Why?
| | Microscopy, Fluorescence | 3 | 2016 | 396 | 0.210 |
Why?
| | Lipase | 2 | 2021 | 55 | 0.210 |
Why?
| | Male | 21 | 2022 | 55599 | 0.210 |
Why?
| | Cell Adhesion Molecules | 1 | 2024 | 168 | 0.210 |
Why?
| | Exotoxins | 2 | 2013 | 14 | 0.210 |
Why?
| | Granulomatous Disease, Chronic | 1 | 2023 | 60 | 0.210 |
Why?
| | Staphylococcus hominis | 1 | 2022 | 1 | 0.200 |
Why?
| | DNA Transposable Elements | 4 | 2010 | 101 | 0.200 |
Why?
| | Cephalexin | 1 | 2022 | 8 | 0.200 |
Why?
| | Genotype | 4 | 2019 | 1760 | 0.200 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2023 | 160 | 0.200 |
Why?
| | Cell Communication | 2 | 2018 | 280 | 0.190 |
Why?
| | Bacterial Load | 4 | 2015 | 58 | 0.190 |
Why?
| | Polysaccharides, Bacterial | 3 | 2017 | 66 | 0.190 |
Why?
| | Epidermis | 2 | 2020 | 149 | 0.190 |
Why?
| | Basophils | 1 | 2021 | 64 | 0.190 |
Why?
| | Arthritis, Infectious | 1 | 2022 | 49 | 0.190 |
Why?
| | Cell Death | 2 | 2021 | 323 | 0.190 |
Why?
| | Lectins | 1 | 2021 | 42 | 0.190 |
Why?
| | Macrophages | 4 | 2023 | 1263 | 0.190 |
Why?
| | Interleukin-17 | 2 | 2019 | 104 | 0.180 |
Why?
| | Propionibacteriaceae | 1 | 2020 | 1 | 0.180 |
Why?
| | Pyruvic Acid | 1 | 2001 | 42 | 0.180 |
Why?
| | Polymerase Chain Reaction | 3 | 2016 | 993 | 0.180 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2001 | 64 | 0.180 |
Why?
| | Hair Follicle | 1 | 2021 | 44 | 0.180 |
Why?
| | Interleukin-4 | 1 | 2021 | 206 | 0.180 |
Why?
| | Molecular Structure | 4 | 2020 | 434 | 0.180 |
Why?
| | Orthopedic Equipment | 1 | 2020 | 5 | 0.180 |
Why?
| | Chemotaxis | 1 | 2021 | 130 | 0.180 |
Why?
| | Electrophoresis, Gel, Pulsed-Field | 2 | 2018 | 17 | 0.180 |
Why?
| | Dysbiosis | 1 | 2022 | 146 | 0.180 |
Why?
| | Phage Therapy | 1 | 2020 | 6 | 0.180 |
Why?
| | Photochemotherapy | 1 | 2020 | 29 | 0.180 |
Why?
| | Photosensitizing Agents | 1 | 2020 | 26 | 0.180 |
Why?
| | Fatty Acids, Volatile | 1 | 2020 | 47 | 0.180 |
Why?
| | Shear Strength | 1 | 2020 | 65 | 0.180 |
Why?
| | Genomics | 1 | 2005 | 635 | 0.180 |
Why?
| | Drug Resistance, Microbial | 1 | 2020 | 66 | 0.180 |
Why?
| | Netherton Syndrome | 1 | 2020 | 2 | 0.170 |
Why?
| | Triterpenes | 1 | 2020 | 17 | 0.170 |
Why?
| | Enzyme Inhibitors | 4 | 2008 | 750 | 0.170 |
Why?
| | Antigens, Bacterial | 1 | 2020 | 112 | 0.170 |
Why?
| | Protein Structure, Tertiary | 3 | 2014 | 796 | 0.170 |
Why?
| | Bacteria | 3 | 2023 | 725 | 0.170 |
Why?
| | Prosthesis-Related Infections | 2 | 2011 | 70 | 0.170 |
Why?
| | Antibodies, Bacterial | 1 | 2020 | 119 | 0.170 |
Why?
| | Gene Expression Profiling | 6 | 2019 | 1518 | 0.170 |
Why?
| | Pyrazines | 1 | 2020 | 71 | 0.170 |
Why?
| | Blotting, Western | 4 | 2016 | 1147 | 0.170 |
Why?
| | Extracellular Vesicles | 1 | 2021 | 83 | 0.170 |
Why?
| | Gene Deletion | 4 | 2014 | 356 | 0.170 |
Why?
| | Streptococcus agalactiae | 2 | 2023 | 81 | 0.170 |
Why?
| | Coleoptera | 1 | 2019 | 24 | 0.170 |
Why?
| | Blotting, Southwestern | 1 | 2019 | 2 | 0.170 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 2 | 2013 | 41 | 0.170 |
Why?
| | Luciferases | 1 | 2019 | 142 | 0.160 |
Why?
| | Leishmania major | 1 | 2019 | 6 | 0.160 |
Why?
| | Leishmaniasis, Cutaneous | 1 | 2019 | 7 | 0.160 |
Why?
| | Fruit | 1 | 2020 | 127 | 0.160 |
Why?
| | Cathelicidins | 4 | 2023 | 38 | 0.160 |
Why?
| | Static Electricity | 1 | 2019 | 114 | 0.160 |
Why?
| | Skin Diseases | 2 | 2019 | 122 | 0.160 |
Why?
| | Lung | 5 | 2022 | 3561 | 0.160 |
Why?
| | Reactive Oxygen Species | 1 | 2021 | 531 | 0.160 |
Why?
| | Models, Genetic | 2 | 2016 | 562 | 0.160 |
Why?
| | Multilocus Sequence Typing | 1 | 2018 | 12 | 0.160 |
Why?
| | Pneumonia, Staphylococcal | 2 | 2018 | 13 | 0.150 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2019 | 161 | 0.150 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2016 | 192 | 0.150 |
Why?
| | Pseudomonas Infections | 1 | 2019 | 184 | 0.150 |
Why?
| | Environmental Microbiology | 1 | 2018 | 43 | 0.150 |
Why?
| | Whole Genome Sequencing | 1 | 2018 | 94 | 0.150 |
Why?
| | Transcription, Genetic | 3 | 2008 | 1313 | 0.150 |
Why?
| | NADPH Oxidases | 2 | 2021 | 120 | 0.150 |
Why?
| | Imaging, Three-Dimensional | 1 | 2021 | 512 | 0.150 |
Why?
| | Bordetella bronchiseptica | 1 | 2017 | 1 | 0.150 |
Why?
| | Bordetella Infections | 1 | 2017 | 2 | 0.150 |
Why?
| | Teichoic Acids | 2 | 2022 | 12 | 0.150 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2019 | 219 | 0.140 |
Why?
| | Influenza, Human | 1 | 2022 | 546 | 0.140 |
Why?
| | Protein Processing, Post-Translational | 2 | 2017 | 399 | 0.140 |
Why?
| | Cell Line | 4 | 2015 | 2637 | 0.140 |
Why?
| | Gastrointestinal Microbiome | 1 | 2023 | 501 | 0.140 |
Why?
| | Culture Media | 3 | 2012 | 155 | 0.140 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2017 | 61 | 0.140 |
Why?
| | Endocarditis, Bacterial | 2 | 2013 | 36 | 0.130 |
Why?
| | Amoxicillin | 1 | 2016 | 20 | 0.130 |
Why?
| | Ligases | 1 | 2016 | 30 | 0.130 |
Why?
| | Sphingomyelin Phosphodiesterase | 1 | 2016 | 21 | 0.130 |
Why?
| | Vascular Access Devices | 1 | 2016 | 24 | 0.130 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 1999 | 333 | 0.130 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2016 | 72 | 0.130 |
Why?
| | Hyaluronoglucosaminidase | 1 | 2015 | 9 | 0.130 |
Why?
| | Leukocidins | 1 | 2015 | 2 | 0.130 |
Why?
| | Trachea | 1 | 2017 | 224 | 0.130 |
Why?
| | Periplasmic Binding Proteins | 1 | 2015 | 14 | 0.120 |
Why?
| | Emodin | 1 | 2015 | 3 | 0.120 |
Why?
| | Gene Knockdown Techniques | 1 | 2016 | 299 | 0.120 |
Why?
| | Carbon | 2 | 2013 | 156 | 0.120 |
Why?
| | Multigene Family | 2 | 2013 | 190 | 0.120 |
Why?
| | Toll-Like Receptor 2 | 4 | 2021 | 110 | 0.120 |
Why?
| | Enterotoxins | 2 | 2013 | 88 | 0.120 |
Why?
| | beta-Defensins | 1 | 2014 | 18 | 0.120 |
Why?
| | Penicillium | 1 | 2014 | 6 | 0.120 |
Why?
| | Anthraquinones | 1 | 2014 | 9 | 0.120 |
Why?
| | Plant Leaves | 1 | 2015 | 110 | 0.120 |
Why?
| | Histocytochemistry | 1 | 2014 | 78 | 0.120 |
Why?
| | Quinazolinones | 1 | 2014 | 19 | 0.120 |
Why?
| | Structural Homology, Protein | 1 | 2014 | 23 | 0.120 |
Why?
| | Phosphoinositide Phospholipase C | 1 | 2014 | 4 | 0.110 |
Why?
| | Agglutination | 1 | 2013 | 5 | 0.110 |
Why?
| | Virus Cultivation | 1 | 2014 | 25 | 0.110 |
Why?
| | Organisms, Genetically Modified | 1 | 2013 | 15 | 0.110 |
Why?
| | Methionine Sulfoxide Reductases | 1 | 2013 | 3 | 0.110 |
Why?
| | DNA | 3 | 2022 | 1352 | 0.110 |
Why?
| | Cysteine | 2 | 2018 | 171 | 0.110 |
Why?
| | Nociceptors | 1 | 2013 | 15 | 0.110 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2014 | 162 | 0.110 |
Why?
| | Heparitin Sulfate | 2 | 2023 | 39 | 0.110 |
Why?
| | Acyl-Butyrolactones | 1 | 2013 | 10 | 0.110 |
Why?
| | Cell Proliferation | 1 | 2020 | 2187 | 0.110 |
Why?
| | Transcription Factors | 5 | 2022 | 1528 | 0.110 |
Why?
| | Erythrocytes | 2 | 2015 | 591 | 0.110 |
Why?
| | Triazoles | 1 | 2014 | 131 | 0.110 |
Why?
| | Receptors, LDL | 1 | 2013 | 38 | 0.110 |
Why?
| | Nitric Oxide | 1 | 2018 | 823 | 0.110 |
Why?
| | Apolipoproteins B | 1 | 2013 | 41 | 0.110 |
Why?
| | Blotting, Northern | 1 | 2013 | 193 | 0.100 |
Why?
| | Transcription Initiation Site | 1 | 2013 | 40 | 0.100 |
Why?
| | Endopeptidase K | 2 | 2013 | 14 | 0.100 |
Why?
| | Surface Properties | 2 | 2014 | 387 | 0.100 |
Why?
| | Protein Transport | 1 | 2014 | 395 | 0.100 |
Why?
| | Receptors, Interleukin-8B | 1 | 2012 | 23 | 0.100 |
Why?
| | Plants, Medicinal | 1 | 2012 | 19 | 0.100 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2013 | 70 | 0.100 |
Why?
| | Alleles | 3 | 2020 | 789 | 0.100 |
Why?
| | Culture Media, Conditioned | 3 | 2020 | 105 | 0.100 |
Why?
| | Mycoplasma fermentans | 1 | 2012 | 1 | 0.100 |
Why?
| | Mutagenesis, Insertional | 3 | 2009 | 61 | 0.100 |
Why?
| | Phenol | 1 | 2012 | 18 | 0.100 |
Why?
| | Incidence | 1 | 2018 | 2313 | 0.100 |
Why?
| | Enzyme Therapy | 1 | 2011 | 4 | 0.100 |
Why?
| | Tetracyclines | 1 | 2011 | 5 | 0.100 |
Why?
| | Cystic Fibrosis | 2 | 2012 | 955 | 0.100 |
Why?
| | Vancomycin | 1 | 2013 | 75 | 0.100 |
Why?
| | Binding Sites | 3 | 2011 | 1168 | 0.100 |
Why?
| | Nucleic Acid Synthesis Inhibitors | 1 | 2011 | 17 | 0.100 |
Why?
| | Ribosomes | 1 | 2013 | 148 | 0.100 |
Why?
| | Protein Synthesis Inhibitors | 1 | 2011 | 42 | 0.100 |
Why?
| | DNA Mutational Analysis | 1 | 2012 | 372 | 0.100 |
Why?
| | Substrate Specificity | 3 | 2007 | 352 | 0.100 |
Why?
| | Microarray Analysis | 3 | 2019 | 118 | 0.100 |
Why?
| | Conserved Sequence | 1 | 2011 | 218 | 0.090 |
Why?
| | Sequence Alignment | 1 | 2011 | 323 | 0.090 |
Why?
| | RNA Polymerase III | 1 | 2010 | 25 | 0.090 |
Why?
| | Membrane Glycoproteins | 1 | 2013 | 430 | 0.090 |
Why?
| | Ethanol | 1 | 2015 | 538 | 0.090 |
Why?
| | Protease Inhibitors | 2 | 2010 | 97 | 0.090 |
Why?
| | Autolysis | 1 | 2010 | 3 | 0.090 |
Why?
| | Citrate (si)-Synthase | 2 | 2001 | 46 | 0.090 |
Why?
| | Chronic Disease | 1 | 2016 | 1578 | 0.090 |
Why?
| | Biological Products | 1 | 2013 | 166 | 0.090 |
Why?
| | Pheromones | 1 | 2010 | 24 | 0.090 |
Why?
| | Complement C3 | 1 | 2011 | 188 | 0.090 |
Why?
| | Cytokines | 4 | 2023 | 1841 | 0.090 |
Why?
| | Epistasis, Genetic | 1 | 2010 | 67 | 0.080 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2014 | 685 | 0.080 |
Why?
| | Leukocytes, Mononuclear | 1 | 2012 | 493 | 0.080 |
Why?
| | Arthroplasty, Replacement | 1 | 2010 | 44 | 0.080 |
Why?
| | Shock, Septic | 1 | 2011 | 186 | 0.080 |
Why?
| | Titanium | 1 | 2010 | 72 | 0.080 |
Why?
| | N-Acetylmuramoyl-L-alanine Amidase | 1 | 2009 | 8 | 0.080 |
Why?
| | Ligands | 1 | 2011 | 562 | 0.080 |
Why?
| | Extracellular Matrix Proteins | 1 | 2010 | 127 | 0.080 |
Why?
| | Kinetics | 3 | 2015 | 1551 | 0.080 |
Why?
| | Time Factors | 5 | 2020 | 6116 | 0.080 |
Why?
| | Phenylmethylsulfonyl Fluoride | 1 | 2008 | 3 | 0.080 |
Why?
| | Alcoholism | 1 | 2015 | 713 | 0.080 |
Why?
| | Prosthesis Design | 1 | 2010 | 285 | 0.080 |
Why?
| | Real-Time Polymerase Chain Reaction | 3 | 2014 | 313 | 0.080 |
Why?
| | Mice, Knockout | 4 | 2018 | 2570 | 0.080 |
Why?
| | Polymers | 2 | 2022 | 448 | 0.070 |
Why?
| | Lipopolysaccharides | 1 | 2011 | 823 | 0.070 |
Why?
| | Gene Knockout Techniques | 3 | 2013 | 98 | 0.070 |
Why?
| | Pain | 1 | 2013 | 705 | 0.070 |
Why?
| | Endopeptidase Clp | 1 | 2007 | 4 | 0.070 |
Why?
| | Sequence Analysis, RNA | 2 | 2019 | 385 | 0.070 |
Why?
| | Genetic Complementation Test | 3 | 2014 | 62 | 0.070 |
Why?
| | Drug Synergism | 2 | 2020 | 316 | 0.070 |
Why?
| | beta-Lactamases | 1 | 2007 | 25 | 0.070 |
Why?
| | Aged, 80 and over | 1 | 2018 | 6347 | 0.070 |
Why?
| | Burns | 1 | 2010 | 237 | 0.070 |
Why?
| | Acyl Coenzyme A | 3 | 2003 | 30 | 0.070 |
Why?
| | Acute Kidney Injury | 1 | 2013 | 638 | 0.070 |
Why?
| | Stimulation, Chemical | 1 | 2006 | 56 | 0.070 |
Why?
| | 4-Butyrolactone | 1 | 2006 | 19 | 0.070 |
Why?
| | Respiratory Tract Infections | 1 | 2010 | 319 | 0.070 |
Why?
| | Interleukin-8 | 2 | 2021 | 237 | 0.070 |
Why?
| | Biocompatible Materials | 1 | 2010 | 369 | 0.070 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2006 | 57 | 0.060 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2010 | 345 | 0.060 |
Why?
| | DNA Primers | 1 | 2006 | 510 | 0.060 |
Why?
| | Genetic Vectors | 1 | 2006 | 289 | 0.060 |
Why?
| | Flow Cytometry | 1 | 2009 | 1083 | 0.060 |
Why?
| | Inhibitory Concentration 50 | 2 | 2016 | 74 | 0.060 |
Why?
| | Sequence Analysis, DNA | 2 | 2014 | 723 | 0.060 |
Why?
| | Combinatorial Chemistry Techniques | 1 | 2005 | 16 | 0.060 |
Why?
| | Phenotype | 3 | 2021 | 2796 | 0.060 |
Why?
| | HIV Protease | 1 | 2004 | 3 | 0.060 |
Why?
| | Genetic Techniques | 1 | 2005 | 58 | 0.060 |
Why?
| | Tacrolimus Binding Protein 1A | 1 | 2004 | 7 | 0.060 |
Why?
| | Interleukin-1beta | 2 | 2019 | 370 | 0.060 |
Why?
| | Ribonucleotide Reductases | 1 | 2004 | 21 | 0.060 |
Why?
| | Two-Hybrid System Techniques | 1 | 2004 | 52 | 0.060 |
Why?
| | Middle Aged | 3 | 2020 | 26737 | 0.060 |
Why?
| | Aged | 2 | 2023 | 19074 | 0.060 |
Why?
| | Bacillus subtilis | 2 | 2020 | 58 | 0.060 |
Why?
| | Tricarboxylic Acids | 1 | 2004 | 10 | 0.060 |
Why?
| | Tetrahydrofolate Dehydrogenase | 1 | 2004 | 14 | 0.060 |
Why?
| | Computational Biology | 2 | 2005 | 530 | 0.060 |
Why?
| | DNA Restriction Enzymes | 1 | 2004 | 54 | 0.060 |
Why?
| | Databases, Genetic | 1 | 2005 | 206 | 0.060 |
Why?
| | Indicators and Reagents | 1 | 2004 | 99 | 0.060 |
Why?
| | Oligosaccharides | 1 | 2023 | 46 | 0.060 |
Why?
| | Catalysis | 2 | 2002 | 289 | 0.050 |
Why?
| | Neutrophil Infiltration | 2 | 2015 | 96 | 0.050 |
Why?
| | Sirolimus | 1 | 2004 | 181 | 0.050 |
Why?
| | Adult | 3 | 2020 | 30550 | 0.050 |
Why?
| | Oxidative Stress | 3 | 2014 | 1076 | 0.050 |
Why?
| | Coenzyme A | 1 | 2003 | 6 | 0.050 |
Why?
| | Acetate-CoA Ligase | 1 | 2003 | 2 | 0.050 |
Why?
| | Cell Wall | 2 | 2013 | 52 | 0.050 |
Why?
| | Apoptosis | 1 | 2012 | 2363 | 0.050 |
Why?
| | Adenosine Monophosphate | 1 | 2003 | 49 | 0.050 |
Why?
| | Recombinases | 1 | 2022 | 6 | 0.050 |
Why?
| | Cefadroxil | 1 | 2022 | 6 | 0.050 |
Why?
| | Cephalothin | 1 | 2022 | 6 | 0.050 |
Why?
| | Oxacillin | 1 | 2022 | 6 | 0.050 |
Why?
| | Protein Stability | 2 | 2013 | 157 | 0.050 |
Why?
| | Methicillin | 1 | 2022 | 11 | 0.050 |
Why?
| | Leukocytes | 2 | 2015 | 276 | 0.050 |
Why?
| | Cefazolin | 1 | 2022 | 18 | 0.050 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 797 | 0.050 |
Why?
| | Brain | 1 | 2013 | 2371 | 0.050 |
Why?
| | Green Fluorescent Proteins | 2 | 2016 | 371 | 0.050 |
Why?
| | Alkyl and Aryl Transferases | 1 | 2002 | 34 | 0.050 |
Why?
| | Sugar Alcohols | 1 | 2002 | 3 | 0.050 |
Why?
| | Cryoprotective Agents | 1 | 2002 | 10 | 0.050 |
Why?
| | U937 Cells | 2 | 2012 | 22 | 0.050 |
Why?
| | Hydrodynamics | 1 | 2022 | 37 | 0.050 |
Why?
| | Viscosity | 1 | 2022 | 81 | 0.050 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2004 | 358 | 0.050 |
Why?
| | Ecosystem | 1 | 2006 | 502 | 0.050 |
Why?
| | Proteolysis | 2 | 2012 | 142 | 0.050 |
Why?
| | Tyrosine | 1 | 2022 | 214 | 0.050 |
Why?
| | Models, Chemical | 2 | 2002 | 248 | 0.050 |
Why?
| | Toll-Like Receptor 1 | 1 | 2021 | 11 | 0.050 |
Why?
| | Propylene Glycol | 2 | 1998 | 9 | 0.050 |
Why?
| | Hemolysis | 2 | 2013 | 146 | 0.050 |
Why?
| | Lipoylation | 1 | 2021 | 16 | 0.050 |
Why?
| | Photorhabdus | 1 | 2001 | 1 | 0.050 |
Why?
| | Protein Conformation | 3 | 2016 | 805 | 0.050 |
Why?
| | Transferases (Other Substituted Phosphate Groups) | 1 | 2001 | 3 | 0.050 |
Why?
| | Aconitic Acid | 1 | 2001 | 1 | 0.050 |
Why?
| | Nematoda | 1 | 2001 | 5 | 0.050 |
Why?
| | Pancreatic Elastase | 1 | 2021 | 66 | 0.050 |
Why?
| | Oxaloacetic Acid | 1 | 2001 | 3 | 0.050 |
Why?
| | Glutamate Synthase | 1 | 2001 | 2 | 0.050 |
Why?
| | Codon, Initiator | 1 | 2001 | 7 | 0.050 |
Why?
| | Cell-Free System | 1 | 2001 | 47 | 0.050 |
Why?
| | Citric Acid Cycle | 1 | 2001 | 43 | 0.050 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2002 | 473 | 0.050 |
Why?
| | Single-Cell Analysis | 1 | 2023 | 188 | 0.050 |
Why?
| | Isobutyrates | 1 | 2020 | 1 | 0.050 |
Why?
| | Pentanoic Acids | 1 | 2020 | 2 | 0.050 |
Why?
| | Hemiterpenes | 1 | 2020 | 11 | 0.050 |
Why?
| | Sequence Deletion | 2 | 2012 | 167 | 0.050 |
Why?
| | Desmoglein 1 | 1 | 2020 | 3 | 0.040 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 318 | 0.040 |
Why?
| | Crystallography, X-Ray | 3 | 2011 | 402 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2002 | 430 | 0.040 |
Why?
| | Colony Count, Microbial | 1 | 2020 | 111 | 0.040 |
Why?
| | Monocytes | 2 | 2013 | 504 | 0.040 |
Why?
| | Chromosome Mapping | 1 | 2001 | 487 | 0.040 |
Why?
| | Intermediate Filament Proteins | 1 | 2019 | 65 | 0.040 |
Why?
| | Recurrence | 1 | 2022 | 935 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2020 | 1842 | 0.040 |
Why?
| | Solubility | 1 | 2020 | 223 | 0.040 |
Why?
| | Phenols | 1 | 2020 | 82 | 0.040 |
Why?
| | Luminescent Measurements | 1 | 2019 | 74 | 0.040 |
Why?
| | Cell Division | 1 | 2001 | 758 | 0.040 |
Why?
| | Carbon Isotopes | 1 | 1999 | 111 | 0.040 |
Why?
| | HeLa Cells | 1 | 2020 | 562 | 0.040 |
Why?
| | Animals, Newborn | 2 | 2012 | 778 | 0.040 |
Why?
| | Th17 Cells | 1 | 2019 | 58 | 0.040 |
Why?
| | Interferon Type I | 1 | 2019 | 128 | 0.040 |
Why?
| | Triglycerides | 1 | 2021 | 467 | 0.040 |
Why?
| | Nucleotidyltransferases | 1 | 1998 | 26 | 0.040 |
Why?
| | Multienzyme Complexes | 1 | 1998 | 64 | 0.040 |
Why?
| | Stress, Mechanical | 1 | 2020 | 445 | 0.040 |
Why?
| | Survival Analysis | 2 | 2012 | 1211 | 0.040 |
Why?
| | Cell Adhesion | 1 | 2019 | 432 | 0.040 |
Why?
| | Iron | 1 | 2019 | 233 | 0.040 |
Why?
| | Tandem Mass Spectrometry | 1 | 2020 | 412 | 0.040 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2018 | 157 | 0.040 |
Why?
| | Diagnostic Imaging | 1 | 2019 | 275 | 0.040 |
Why?
| | Toxins, Biological | 1 | 2017 | 11 | 0.040 |
Why?
| | Nose | 1 | 2017 | 55 | 0.040 |
Why?
| | Immunoglobulin G | 2 | 2011 | 770 | 0.040 |
Why?
| | Genes, Regulator | 1 | 1997 | 34 | 0.030 |
Why?
| | Blood Coagulation | 1 | 2018 | 218 | 0.030 |
Why?
| | Soft Tissue Infections | 1 | 2017 | 30 | 0.030 |
Why?
| | Interferon-gamma | 1 | 2019 | 719 | 0.030 |
Why?
| | Necrosis | 1 | 2017 | 211 | 0.030 |
Why?
| | Child | 3 | 2022 | 18415 | 0.030 |
Why?
| | Ethanolamines | 1 | 1995 | 19 | 0.030 |
Why?
| | Bronchi | 1 | 2017 | 232 | 0.030 |
Why?
| | Propylene Glycols | 1 | 1995 | 25 | 0.030 |
Why?
| | DNA Polymerase I | 1 | 1995 | 26 | 0.030 |
Why?
| | Cell Movement | 1 | 2019 | 869 | 0.030 |
Why?
| | Homeostasis | 1 | 2019 | 573 | 0.030 |
Why?
| | Hypersensitivity, Delayed | 1 | 2015 | 27 | 0.030 |
Why?
| | Interleukin-23 | 1 | 2015 | 15 | 0.030 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2015 | 59 | 0.030 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 2015 | 97 | 0.030 |
Why?
| | Mice, Hairless | 1 | 2014 | 74 | 0.030 |
Why?
| | Oligonucleotide Probes | 1 | 2014 | 54 | 0.030 |
Why?
| | Cell Line, Transformed | 1 | 2014 | 133 | 0.030 |
Why?
| | Pyomyositis | 1 | 2014 | 13 | 0.030 |
Why?
| | Neisseria gonorrhoeae | 1 | 2014 | 20 | 0.030 |
Why?
| | Hypochlorous Acid | 1 | 2013 | 4 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2021 | 1880 | 0.030 |
Why?
| | Molecular Docking Simulation | 1 | 2014 | 101 | 0.030 |
Why?
| | Molecular Conformation | 1 | 2014 | 135 | 0.030 |
Why?
| | Cerebral Ventricles | 1 | 2013 | 47 | 0.030 |
Why?
| | NAV1.8 Voltage-Gated Sodium Channel | 1 | 2013 | 4 | 0.030 |
Why?
| | Myeloid Cells | 1 | 2015 | 126 | 0.030 |
Why?
| | Lymphatic Diseases | 1 | 2013 | 17 | 0.030 |
Why?
| | N-Formylmethionine Leucyl-Phenylalanine | 1 | 2013 | 65 | 0.030 |
Why?
| | Fluorescence | 1 | 2014 | 148 | 0.030 |
Why?
| | Glyoxylates | 1 | 2013 | 9 | 0.030 |
Why?
| | Host Specificity | 1 | 2013 | 22 | 0.030 |
Why?
| | Aging | 1 | 2023 | 1618 | 0.030 |
Why?
| | Fermentation | 1 | 2013 | 21 | 0.030 |
Why?
| | Oxidants | 1 | 2013 | 112 | 0.030 |
Why?
| | Immunocompromised Host | 1 | 2015 | 195 | 0.030 |
Why?
| | Vancomycin Resistance | 1 | 2013 | 15 | 0.030 |
Why?
| | Carbohydrates | 1 | 2013 | 55 | 0.030 |
Why?
| | NADPH Oxidase 2 | 1 | 2013 | 42 | 0.030 |
Why?
| | Disease Susceptibility | 1 | 2015 | 316 | 0.030 |
Why?
| | Animals, Outbred Strains | 1 | 2012 | 3 | 0.030 |
Why?
| | Oligonucleotides | 1 | 2014 | 137 | 0.030 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2013 | 90 | 0.030 |
Why?
| | Regulon | 1 | 2013 | 32 | 0.030 |
Why?
| | High-Throughput Screening Assays | 1 | 2014 | 123 | 0.030 |
Why?
| | Daptomycin | 1 | 2012 | 18 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2540 | 0.030 |
Why?
| | Surface Plasmon Resonance | 1 | 2013 | 81 | 0.030 |
Why?
| | Hyperalgesia | 1 | 2013 | 107 | 0.030 |
Why?
| | Acetates | 1 | 2013 | 95 | 0.030 |
Why?
| | Immunoassay | 1 | 2013 | 95 | 0.030 |
Why?
| | T-Lymphocyte Subsets | 1 | 2015 | 383 | 0.030 |
Why?
| | Sus scrofa | 1 | 2012 | 45 | 0.030 |
Why?
| | Peritonitis | 1 | 2013 | 77 | 0.030 |
Why?
| | Ion Transport | 1 | 2012 | 55 | 0.030 |
Why?
| | Bicarbonates | 1 | 2012 | 41 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2015 | 419 | 0.030 |
Why?
| | Body Fluids | 1 | 2012 | 58 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2014 | 785 | 0.020 |
Why?
| | Chemotaxis, Leukocyte | 1 | 2012 | 130 | 0.020 |
Why?
| | Crystallization | 2 | 2003 | 136 | 0.020 |
Why?
| | Hydrogen Peroxide | 1 | 2013 | 288 | 0.020 |
Why?
| | Fluorescent Dyes | 1 | 2014 | 301 | 0.020 |
Why?
| | Cell Membrane Permeability | 1 | 2012 | 83 | 0.020 |
Why?
| | Neutrophil Activation | 1 | 2012 | 94 | 0.020 |
Why?
| | Hot Temperature | 1 | 2013 | 302 | 0.020 |
Why?
| | Glycerophosphates | 1 | 2011 | 2 | 0.020 |
Why?
| | Chromatography, Thin Layer | 1 | 2011 | 24 | 0.020 |
Why?
| | Calcium Signaling | 1 | 2013 | 217 | 0.020 |
Why?
| | Molecular Targeted Therapy | 1 | 2014 | 347 | 0.020 |
Why?
| | Complement C3-C5 Convertases | 1 | 2011 | 19 | 0.020 |
Why?
| | Immunoglobulin Fragments | 1 | 2011 | 15 | 0.020 |
Why?
| | Toll-Like Receptor 9 | 1 | 2011 | 30 | 0.020 |
Why?
| | Rodent Diseases | 1 | 2011 | 25 | 0.020 |
Why?
| | Complement C3b | 1 | 2011 | 30 | 0.020 |
Why?
| | Mupirocin | 1 | 2010 | 7 | 0.020 |
Why?
| | Complement C3a | 1 | 2011 | 33 | 0.020 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2011 | 134 | 0.020 |
Why?
| | Bacitracin | 1 | 2010 | 6 | 0.020 |
Why?
| | Polymyxin B | 1 | 2010 | 21 | 0.020 |
Why?
| | Neomycin | 1 | 2010 | 7 | 0.020 |
Why?
| | Ointments | 1 | 2010 | 23 | 0.020 |
Why?
| | Models, Immunological | 1 | 2011 | 92 | 0.020 |
Why?
| | Bacteriolysis | 1 | 2010 | 9 | 0.020 |
Why?
| | Immunoblotting | 1 | 2011 | 283 | 0.020 |
Why?
| | Gentamicins | 1 | 2010 | 42 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 923 | 0.020 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2011 | 195 | 0.020 |
Why?
| | Action Potentials | 1 | 2013 | 406 | 0.020 |
Why?
| | Protein Interaction Mapping | 1 | 2011 | 101 | 0.020 |
Why?
| | Meconium | 1 | 2010 | 7 | 0.020 |
Why?
| | Ileus | 1 | 2010 | 10 | 0.020 |
Why?
| | Stress, Physiological | 1 | 2013 | 378 | 0.020 |
Why?
| | Deoxyribonucleases | 1 | 2010 | 21 | 0.020 |
Why?
| | Fatty Acids | 1 | 2013 | 381 | 0.020 |
Why?
| | Weight Loss | 1 | 2015 | 642 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2012 | 591 | 0.020 |
Why?
| | Up-Regulation | 1 | 2013 | 808 | 0.020 |
Why?
| | Bacterial Infections | 1 | 2012 | 218 | 0.020 |
Why?
| | Mucus | 1 | 2010 | 54 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 2010 | 396 | 0.020 |
Why?
| | Cell-Derived Microparticles | 1 | 2010 | 57 | 0.020 |
Why?
| | Pancreatic Diseases | 1 | 2010 | 64 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2014 | 2218 | 0.020 |
Why?
| | Glycoproteins | 1 | 2011 | 304 | 0.020 |
Why?
| | Sheep | 1 | 2012 | 764 | 0.020 |
Why?
| | Deoxyribonuclease I | 1 | 2009 | 34 | 0.020 |
Why?
| | Radiography, Thoracic | 1 | 2010 | 150 | 0.020 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2012 | 287 | 0.020 |
Why?
| | Oxygen | 1 | 2013 | 854 | 0.020 |
Why?
| | Complement Activation | 1 | 2011 | 340 | 0.020 |
Why?
| | Pregnancy | 1 | 2019 | 5518 | 0.020 |
Why?
| | Transcriptome | 1 | 2013 | 725 | 0.020 |
Why?
| | Immunosuppressive Agents | 1 | 2012 | 646 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2010 | 951 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2010 | 1226 | 0.020 |
Why?
| | Caulobacter crescentus | 1 | 2007 | 1 | 0.020 |
Why?
| | B-Lymphocytes | 1 | 2012 | 766 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2011 | 1949 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2013 | 2765 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2013 | 2553 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2320 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2012 | 1737 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2013 | 2128 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2014 | 3053 | 0.010 |
Why?
| | Binding, Competitive | 1 | 2003 | 193 | 0.010 |
Why?
| | Acetylation | 1 | 2003 | 211 | 0.010 |
Why?
| | Adolescent | 1 | 2020 | 17848 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 2004 | 616 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2001 | 522 | 0.010 |
Why?
| | Reproduction | 1 | 2001 | 178 | 0.010 |
Why?
| | Pentosyltransferases | 1 | 1998 | 3 | 0.010 |
Why?
| | Ethanolamine | 1 | 1995 | 5 | 0.010 |
Why?
| | Sequence Analysis | 1 | 1995 | 35 | 0.010 |
Why?
| | Rats | 1 | 1995 | 4958 | 0.000 |
Why?
|
|
Horswill's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|